OGI.TO - OrganiGram Holdings Inc.

Toronto - Toronto Delayed Price. Currency in CAD
2.4200
-0.1600 (-6.20%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.5800
Open2.4000
Bid2.3700 x N/A
Ask2.3800 x N/A
Day's Range2.3100 - 2.5400
52 Week Range1.5400 - 10.2100
Volume2,284,794
Avg. Volume1,476,626
Market Cap418.851M
Beta (5Y Monthly)1.93
PE Ratio (TTM)N/A
EPS (TTM)-0.2570
Earnings DateJul. 13, 2020 - Jul. 17, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.54
  • Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal
    Business Wire

    Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal

    Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that the Company has amended its credit agreement dated May 31, 2019, with Bank of Montreal ("BMO") as lead arranger and agent as well as a syndicate including three other lenders (the "Credit Agreement Amendment"). The Credit Agreement Amendment modifies certain terms of the $115 million term loan (the "Term Loan") and $25 million revolving credit facility (the "Revolver", and together with the Term Loan, the "Facilities").

  • Why Tilray and OrganiGram Holdings Got Slammed on Friday
    Motley Fool

    Why Tilray and OrganiGram Holdings Got Slammed on Friday

    A pair of marijuana stocks, Tilray (NASDAQ: TLRY) and OrganiGram Holdings (NASDAQ: OGI), both dropped notably in price on Friday (by 5.2% and 7%, respectively). The culprit seems to be another weed title, Canopy Growth (NYSE: CGC), which earlier in the day published an awful quarterly earnings release. Canopy Growth is a leading company in the sector.

  • Why Organigram Stock Surged Today
    Motley Fool

    Why Organigram Stock Surged Today

    Shares of Organigram Holdings (NASDAQ: OGI) were flying on Thursday after the company said it was rolling out its "cannabis 2.0" products to its medical marijuana customers. As of 3:27 p.m. EDT, Organigram's stock was up more than 12%. Cannabis 2.0 is a term used to describe second-generation marijuana products such as edibles and beverages, as opposed to cannabis 1.0 products like dried flower.

  • OrganiGram Releases Cannabis 2.0 Products To Medical Users
    Motley Fool

    OrganiGram Releases Cannabis 2.0 Products To Medical Users

    Vapes and chocolate edibles are among the new cannabis products the company is rolling out to medical marijuana consumers.

  • Organigram Rolls out Cannabis 2.0 Products to Medical Consumers
    Business Wire

    Organigram Rolls out Cannabis 2.0 Products to Medical Consumers

    Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that as of May 19th, 2020, the Company has extended its medical cannabis offering to include products from its cannabis 2.0 adult-use recreational portfolio.

  • Got $3,000? These 5 Beaten-Down Stocks Are Begging to Be Bought
    Motley Fool

    Got $3,000? These 5 Beaten-Down Stocks Are Begging to Be Bought

    No matter how dire things may have appeared in previous bear markets, bull-market rallies eventually erase all evidence of downward moves in the stock market. Also keep in mind that you don't have to be rich to generate a handsome return from the stock market. With the exception of the oil and gas industry, there's probably not a harder-hit industry lately than bank stocks.

  • Why Aurora Cannabis Stock Is Falling Today
    Motley Fool

    Why Aurora Cannabis Stock Is Falling Today

    Shares of Aurora Cannabis (NYSE: ACB) sank on Wednesday after analysts raised concerns that the popular marijuana stock's price gains may have come too far, too fast. As of 3 p.m. EDT, Aurora's stock was down more than 12%. Aurora's shares surged as much as 180% following the cannabis producer's better-than-expected third-quarter sales results on May 14.

  • 4 Signs the Cannabis Industry Is Still Ultra-High-Risk
    Motley Fool

    4 Signs the Cannabis Industry Is Still Ultra-High-Risk

    If you're looking to invest in the cannabis industry, you have to be prepared to take on some significant risks. The industry's been struggling during the past year, and a turnaround is not necessarily imminent. This year is already setting up to be a challenging one for many pot stocks, and investors should be careful not to be lured in by low prices.

  • Organigram (OGI) Catches Eye: Stock Jumps 11.7%
    Zacks

    Organigram (OGI) Catches Eye: Stock Jumps 11.7%

    Organigram (OGI) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.

  • Why Canopy Growth, Cronos Group, and OrganiGram Soared Today
    Motley Fool

    Why Canopy Growth, Cronos Group, and OrganiGram Soared Today

    Shares of several top Canadian cannabis producers soared today after one of their peers, Aurora Cannabis (NYSE: ACB), reported better-than-expected fiscal 2020 third-quarter revenue growth after the market closed on Thursday. Canopy Growth (NYSE: CGC) stock was up 13.4% as of 3:38 p.m. EDT on Friday, while shares of Cronos Group (NASDAQ: CRON) and OrganiGram Holdings (NASDAQ: OGI) were up 10.3% and 13.5%, respectively. Investors now appear to be increasingly optimistic that the rest of the Canadian cannabis industry could also enjoy a turn for the better after a challenging period following Aurora's surprisingly positive results.

  • OrganiGram Holdings Starts Bringing Employees Back to Work
    Motley Fool

    OrganiGram Holdings Starts Bringing Employees Back to Work

    Around 50 workers will return to the company's New Brunswick headquarters in the opening phase of the plan.

  • Organigram announces first phase of return-to-work strategy
    Business Wire

    Organigram announces first phase of return-to-work strategy

    As it continues to monitor and assess the implications of the COVID-19 pandemic, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, has announced the first phase of its return-to-work strategy. The Company has begun to implement a staggered return-to-work plan effective May 13, 2020.

  • These Pot Stocks May Need to Enact a Reverse Split
    Motley Fool

    These Pot Stocks May Need to Enact a Reverse Split

    Marijuana stocks have plunged so severely that they may need to take drastic measures to avoid being delisted.

  • Court Partially Overturns Class-Action Lawsuit Against OrganiGram Holdings
    Motley Fool

    Court Partially Overturns Class-Action Lawsuit Against OrganiGram Holdings

    The legal action against the cannabis company will continue, but its scope has been considerably reduced.

  • Court Significantly Reduces Scope of Class Action
    Business Wire

    Court Significantly Reduces Scope of Class Action

    MONCTON, New Brunswick--(BUSINESS WIRE)--The Nova Scotia Court of Appeal has partially overturned the certification of a class action (the “Class Action”) against Organigram Inc. (the "Company" or "Organigram") and its parent company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis in Canada, on April 30, 2020 thereby significantly reducing the scope of the claim against the Company.

  • I Still Have Faith in OrganiGram!
    Motley Fool

    I Still Have Faith in OrganiGram!

    Even after its disastrous second-quarter results and subsequent price drop, I'm sold on this cannabis company's COVID-19 strategies and its approach to cannabis 2.0.

  • Which pot stocks will survive? Measuring cannabis bankruptcy risk
    Yahoo Finance Canada

    Which pot stocks will survive? Measuring cannabis bankruptcy risk

    With the global economy withering under the COVID-19 pandemic, the odds of a wave of bankruptcies wiping out underperforming cannabis firms are on the rise.

  • Better Buy: OrganiGram Holdings vs. Canopy Growth
    Motley Fool

    Better Buy: OrganiGram Holdings vs. Canopy Growth

    Both of these stocks are down more than 60% in the past year, but which one is more likely to bounce back?

  • Consumer Research Drives Enhancements to Organigram Adult Recreational Commercial Portfolio
    Business Wire

    Consumer Research Drives Enhancements to Organigram Adult Recreational Commercial Portfolio

    Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to provide an update related to the Company’s current and anticipated releases of new adult use recreational cannabis products.

  • Organigram Holdings Inc. Announces At-The-Market Equity Program
    Business Wire

    Organigram Holdings Inc. Announces At-The-Market Equity Program

    Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX:OGI) (NASDAQ:OGI) announced today that it has established an at-the-market equity program (the "ATM Program") that allows the Corporation to issue up to C$49,000,000 (or its U.S. dollar equivalent) of common shares ("Common Shares") from treasury to the public from time to time, at the Corporation’s discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the "TSX"), the NASDAQ Global Select Market (the "NASDAQ") or any other marketplace on which the Common Shares are listed, quoted or otherwise traded, at the prevailing market price at the time of sale.

  • Aphria, Valens prove pot profit is still a thing
    Yahoo Finance Canada

    Aphria, Valens prove pot profit is still a thing

    Quarterly profits are a rarity in the Canadian cannabis sector, but two large pot companies surprised investors with strong financial results. 

  • Return of laid off Organigram workers will factor in ‘growth in the market’: CEO
    Yahoo Finance Canada

    Return of laid off Organigram workers will factor in ‘growth in the market’: CEO

    When the approximately 400 Organigram workers laid off in response to COVID-19 will be allowed to return to their jobs will depend in part on “growth in the market,” according to the cannabis producer’s chief executive officer.

  • OrganiGram (OGI) Reports Q2 Loss, Lags Revenue Estimates
    Zacks

    OrganiGram (OGI) Reports Q2 Loss, Lags Revenue Estimates

    OrganiGram (OGI) delivered earnings and revenue surprises of -100.00% and -15.60%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Organigram Reports Second Quarter Fiscal 2020 Results
    Business Wire

    Organigram Reports Second Quarter Fiscal 2020 Results

    Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its results for the second quarter ended February 29, 2020 ("Q2" or "Q2 2020").

  • Can Product Innovation Aid OrganiGram (OGI) in Q2 Earnings?
    Zacks

    Can Product Innovation Aid OrganiGram (OGI) in Q2 Earnings?

    OrganiGram (OGI) is expected to have benefited from its focus on building brand equity and ongoing product innovation in the fiscal second quarter.